Liraglutide injection,RD12014
12014-P-01/CRC-C1944
Phase 1 small_molecule completed
Quick answer
Liraglutide injection,RD12014 for Type 2 Diabetes is a Phase 1 program (small_molecule) at Sunshine Biopharma with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Sunshine Biopharma
- Indication
- Type 2 Diabetes
- Phase
- Phase 1
- Modality
- small_molecule
- Status
- completed